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Abstract
The normal tissue complication probability (NTCP) is a measure for the estimated
side effects of a given radiation treatment schedule. Here we use a stochastic logistic
birth death process to define an organ specific and patient specific NTCP. We empha-
sise an asymptotic simplification which relates the NTCP to the solution of a logistic
differential equation. This framework allows for a direct use of the NTCP model in
clinical practice. We formulate, but do not solve, related optimization problems.
Key words: normal tissue complication probability, logistic birth death process, tu-
mor control probability, radiation treatment, side effects, TCP, NTCP
1 Introduction
The goal of radiotherapy is to deliver a sufficient radiation dose to the tumor to provide
a high probability of cure while the surrounding healthy tissue is minimally damaged and
left functionally and architecturally competent. To achieve this goal it is necessary to
have a method of estimating the probability of normal tissue complication. Quantitative
measures for the expected negative side effects on healthy tissue are called Normal Tissue
Complication Probabilities (NTCP) ([11, 13, 15]). In this paper we investigate appropriate
mathematical formulations thereof.
The mathematical formulation of a NTCP is similar to the formulation of the tumor control
probability (TCP), which represents the probability that after a radiation treatment no
cancer cell has survived in the irradiated domain. The aim of treatment is to achieve a
TCP value that converges, or is close, to one. While the TCP is concerned with the damage
to cancerous tissue, the damage of surrounding healthy tissue cells is not included in a
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TCP model. Hence here we develop a cousin model, the NTCP, and we use the existing
TCP models as guidelines for the development of NTCP models for healthy tissue.
The formulation of a useful NTCP model has many challenges. NTCP models must be
patient and organ specific. Details of the organ’s function, the microenvironment, the
biochemical pathways, the geometric structure, and the radio sensitivities are needed. For
each organ (and each patient), we need to estimate a critical size such that the organ can
still function. It is impossible to achieve this in an one-fits-all approach. Here we strive to
prepare the development by providing a mathematical framework in which organ specific
details can be included in an NTCP model. At the same time we strive to find a model
that is not over burdened with complicated mathematics, and rather allows for a simple
inclusion in clinical practice.
The radiation damage to healthy organs and possible organ failures are inertly stochastic
events, which cannot be predicted with certainty. The language of NTCP must, therefore,
come from stochastic processes. In this paper we focus on the mathematical aspects and
we show that
• Logistic birth-death models can be used to define a treatment-, patient-, and organ-
specific NTCP (see Section 3).
• The NTCP can be estimated through the solution of the mean field equations, which
allows for an estimation of a maximal tolerable dose Dmax for each patient (see
Section 4).
• We formulate (but do not solve here) an organ and patient specific optimization
problem for radiation treatment with side effects. We have to leave it to future
research to identify the necessary parameters for each organ/patient, and to perform
the optimization (see Section 5).
Since the TCP and NTCP are closely related, we first review some TCP models before
we extend them to NTCP modelling. One important ingredient is an estimate for the
survival fraction S(d), given a radiation dose d. We will review the corresponding linear
quadratic model (LQ-model) in Section 2, where we also review models for the TCP. In
Section 2.3 and Section 2.4 we discuss the NTCP approaches of Lyman and the critical
volume approach. Section 3 is devoted to our derivation of a stochastic NTCP model
based on a stochastic logistic process [4, 1]. It turns out that the mean field equations of
this process play an important role. Firstly, the mean field equations are of the form of a
standard logistic differential equation plus a perturbation which depends on the variance.
If the variance is small, or if the carrying capacity is large, then the mean field is basically
a logistic equation. Moreover, we show that the region where the NTCP becomes critical
(i.e. NTCP≈ 1) can be approximated by a Heaviside function, where the location of the
jump coincides with the location where the solution of the logistic differential equation falls
below a critical level. This relation is surprising, since the NTCP is an intrinsic stochastic
concept, but it can actually be estimated from a deterministic differential equation. The
same relation arose in the computation of the TCP from Zaider and Minerbo. It was
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never spelled out in [16], but it was shown in [7] that the Zaider-Minerbo TCP can be
computed from the solution of the mean field equations. In Section 4 we motivate the use
of a maximal tolerable dose, based on the organ at hand, the patient’s radio-sensitivities
and the treatment schedule used. We close with a Conclusion section 5 where we formulate
corresponding optimization and optimal control problems.
2 Previous models of cell survival, TCP and NTCP
TCP values are often obtained from statistical models of cell-survival. These are models
that result from long clinical trials and research. Their advantages are simplicity and
effective data-fitting. This is one of the main reasons why they are of high practical
relevance. Unfortunately, they over-simplify important processes, leaving out complex cell
mechanisms like repopulation of the cells and their differing sensitivity to irradiation.
Another approach is TCP derived from cell-population models. These are models that
take the stochasticity in case of a small number of existing cells into consideration. Here
the change of the cell density is described by stochastic processes, for example birth-death
processes [16, 9, 2, 10]. In contrast to the previous method these models consider important
cell dynamics very precisely. We will introduce the Zaider-Minerbo TCP in Section 2.2
and then extend it in Section 3 to NTCP.
Several models have been proposed to derive an NTCP. We review the three most promi-
nent approaches including the Lyman NTCP in Section 2.3, the critical volume NTCP in
Section 2.4, and the use of the Biological Effective Dose in Section 2.5. First, however, we
recall the modelling of the surviving fraction after radiation treatment.
2.1 The linear quadratic model and the hazard function
We use d to denote a radiation dose per fraction in units of Gy, and we use D to denote
the total dose. S(D) is the surviving fraction of the tumor cells and for one radiation dose
d we use the well established linear quadratic model (LQ-model)
S(d) = e−αd−βd
2
.
The parameters α and β are called the radiosensitivities, and they have been measured
for most cancerous tissues in the literature. For fractionated treatment with n fractions
and D = nd, the LQ formula is applied recursively to give
S(D) = e−(α+βd)D. (2.1)
This model has been extended (see [5]) to include tumor re-growth with doubling time Tp
and a re-growth delay Tk as observed in many instances. The extended LQ-model reads
S(D) = exp
(
−α
[
nd
(
1 +
d
α/β
)
− ln 2 (T − Tk)
αTp
])
. (2.2)
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The model manages to include the biological effects like repopulation and healing, how-
ever the complexity of our original model has increased greatly. To quote Fowler: “The
LQ-model loses its innocence when a time factor is added ” [5]. The formula consists of
five unknown parameters instead of one and this leads to massive problems from a medical
point of view as the parameters are difficult to measure.
If more complex treatment schedules are considered, for example unequal dosage, combi-
nation of radioactive seeds and external beam radiation, accelerated treatments etc., we
can use a differential equation approach to define the surviving fraction at time t as
dS(t)
dt
= −h(t)S(t),
with hazard function h(t). The hazard function carries all the details of the treatment
schedule and, as shown in [7], the choice of the hazard function is important. The general
hazard function can be written as
h(t) = (α+ βdeff(t))D˙(t),
where D˙(t) denotes the dose rate and D(t) the total dose as function of time. The term
deff(t) depends on the tissue at hand, on the radiation schedule and on the underlying
physical radiation damage model. It is worthwhile to compare and contrast different
approaches that are used in the literature. The most common are (see also [7]):
(a) deff = d fractionated treatments
(b) deff = 2D(t) Zaider-Minerbo [16]
(c) deff = 2
∫ t
−∞ e
−γ(t−s)D˙(s)ds Leah-Catchside protraction factor
(d) deff = 2(D(t)−D(t− ω)) finite interaction window of single strand breaks
The coefficient γ > 0 describes the exponential repair rate of single strand breaks. The
exponential decay term in (c) leads to a reduced interaction of single strand breaks that
are timely far apart. The coefficient ω > 0 has a similar function as it describes a time
window such that single strand breaks which occur in this time window can interact to
produce a double strand break. In many cases ω ≈ 6h. Details of the modelling of hazard
functions can be found in [7].
In our numerical examples later, we study constant radiation with dose rate d. Using
the above notation we have D˙(t) = d, D(t) = dt and the above choices for deff can be
computed as
(a) deff = d
(b) deff = 2dt (2.3)
(c) deff =
2d
γ
(d) deff = 2dω (2.4)
4
We see that choice (b) is increasing in time, while all other choices are constant. The reason
is that in (b) it is intrinsically assumed that single strand breaks can always interact, no
matter how timely far apart they have been generated. The authors believe that this choice
leads to an over aggressive hazard function. However, this choice is in popular use in the
literature, and we feel obliged to include it here. The expressions for the Leah-Catchside
protraction factor in (c) and for the finite interaction window in (d) are equivalent with
the choice γ−1 = ω.
To illustrate our NTCP method we will later consider two types of tissues with two types
of hazard functions:
• Tissue A: Here we assume the tissue regenerates very quickly if damaged, but
we also assume that single strand breaks persist very long. Hence we choose the
Zaider-Minerbo form of h(t) (2.3).
• Tissue B: Here we consider slow repair, and assume that single strand breaks
interact on a time scale of up to 6h, i.e. we choose the hazard function h(t) from
(2.4).
The corresponding survival fractions for the cases (2.3) and (2.4) can be computed to be
S(t) = e−(α+βdt)dt for (2.3)
S(t) = e−(α+2βdω)dt for (2.4).
2.2 TCP by Zaider and Minerbo
To motivate the TCP model of Zaider and Minerbo [16] we consider a simple ordinary
differential equation for the tumor population density n(t):
dn(t)
dt
= (b− r(t))n(t), n(0) = n0, (2.5)
with b as a constant birth rate and r(t) the removal rate. The removal rate can be written
as the sum of the natural death rate d, which is constant and the radiation dependent
hazard function h(t) giving r(t) = d+ h(t). The solution of this cell population model is
given by
n(t) = n0 exp
(
bt−
∫ t
0
r(s)ds
)
, (2.6)
with n0 indicating the initial number of tumor cells.
For a large initial number of cancer cells, deterministic models are appropriate, because
with the law of large numbers stochastic events can be neglected and the number of cells
converges to the mean number of cells. However, a successful therapy aims to diminish the
number of cancer cells and for low cell numbers the deterministic formulation no longer
applies. Hence we extend the model to include stochastic events via a birth death process.
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Following Zaider and Minerbo [16] we let Pi(t) be the probability that i cells are alive at
time t with i ∈ N. The corresponding Master equation for Pi(t) that describes the change
of cells is then given as:
dPi(t)
dt
= (i− 1)bPi−1(t) + (i+ 1)r(t)Pi+1(t)− i(b+ r(t))Pi(t) (2.7)
setting P−1(t) = 0 and with initial values Pn0(0) = 1 and Pi(0) = 0 for i 6= n0. It can
be easily checked that the expected number of tumor cells n(t) =
∑∞
i=0 iPi(t) satisfies the
above equation (2.5) given that the sum converges. Hence (2.5) appears as mean field
model for the stochastic birth-death process (2.7).
To obtain the TCP we calculate P0(t). This can be done by methods of generating function
(see [16]). Hence we obtain the TCP formula of Zaider-Minerbo as
TCPZM (t) = P0(t) =
[
1− n(t)
n0 + bn0n(t)
∫ t
0
dr
n(r)
]n0
(2.8)
with birth rate b ≥ 0 and removal rate r(t). Here n(t) is the solution (2.6) of the mean
field equation (2.5).
This framework has been extended to include active and quiescent cell compartments
by Dawson and Hillen in [2], non-Poissonian cell cycle times by Maler and Lutscher in
[12], and cancer stem cells by Gong [6]. These models follow the same basic principle of
stochastic processes, but the resulting TCP formulas are much more complicated. In this
paper we base the NTCP- formulation on the Zaider- Minerbo approach, being aware that
further generalizations to include cell cycle and stem cells might be needed in the future.
2.3 The Lyman-Model for NTCP
The first and simplest model for the NTCP is a model developed by Lyman in 1985 [11].
According to his paper “a good treatment plan delivers a high uniform dose to the cancerous
volume and lower dose to the surrounding normal tissues”, also uniformly distributed. To
measure the harm of the radiation on a particular healthy tissue, an organ specific tolerance
dose TDi is used. These are the doses that would result in i % complication probabilities
after 5 years. The tolerance doses can be described by functions that depend on beam
area or fraction of the organ treated. Knowing the tolerance dose of the whole organ the
relation to the tolerance dose of a fractional part v ∈ [0,1] of this organ is given by
TDi(v) = TDi(1)v
−n
with i ∈ [0, 100] and 0 < n ≤ 1 a fitted parameter [13].
According to [11] data implies that normal tissue complication probability is not only
a function of the absorbed dose but also depends on the percentage of the organ volume
irradiated. Keeping the fractional volume v fixed (hence we set TD50(v) = TD50), this
6
Figure 1: NTCPLyman for radiation of the heart as function of dose D and fractional
volume treated v.
results in a sigmoidal-shaped1 NTCP-curve dependent on the total dose D. The formula
introduced in [11] is the integral of a normal distribution with mean value µ = TD50 and
standard derivation approximated by σ = mTD50 receiving
NTCPLyman(D) =
1√
2piσ
∫ D
−∞
e−
1
2
( z−µ
σ
)2dz.
Here m is a parameter that governs the slope of the function, obtained from fitting clinical
data [13]. Rescaling by t = D−TD50mTD50 the formula reduces to a standard normal distribution
and we obtain
NTCPLyman(D) =
1√
2pi
∫ t
−∞
e−
s2
2 ds. (2.9)
This NCTP-formula is completely determined by the three parameters, TD50(1),m and
n. For fixed n,m and for variable partial volume v and total dose D, the NCTP becomes
a surface as shown in Fig. 1. This simulation is run for irradiation with parameters for
the heart as TD50(1) = 41.9, n = 0.5 and m = 0.1 [11].
However, in daily practice the assumption of uniformly distributed dosage on tissue can
be relaxed with the emergence of new technologies, such as CT scanned images, making
computerized treatment planning possible. These methods are able to generate images
that allow for a 3D, non-uniformly distributed dose.
1real valued and differentiable function having either a non-negative or a non-positive first derivative
which is bell shaped
https://www.princeton.edu/ achaney/tmve/wiki100k/docs/Sigmoid function.html
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2.4 The Critical Volume NTCP
Another deterministic model for NTCP is the so-called critical volume NTCP and was first
introduced by Niemierko et al. in [13]. As detailed below, this model is closely related to
the one of Lyman. A variety of organs can still function even when partially destroyed.
This fact is called a parallel organ structure and appears in organs such as the lung and
kidney, because the undamaged parts work independently from the damaged ones [6].
The critical volume model includes this tissue structure of the organ and is therefore more
realistic. The smallest unit of an organ that is capable to perform biological functions is
called a functional subunit (short: FSU) [15]. For example in the kidney the FSU are the
renal tubes, in the liver it is the lobules, and the FSU of the lung are the acinuses. For
the following we assume that an organ consists of N FSUs being identical and uniformly
distributed throughout the organ. Each FSU consists of N0 cells. To destroy one FSU all
N0 cells have to be killed since we assume that a single cell is able to regenerate the FSU
it is belonging to. The probability of damaging a FSU after applying a dose d is described
by PFSU (d). To calculate this probability we use the complement of the LQ-model for
describing the cell death within one FSU. Thus it is
PFSU (d) = (1− e−(αd+βd2))N0 . (2.10)
If we consider a fractionated treatment where the total dose D is divided into n fractions,
not necessarily of equal dose, then (2.10) becomes
PFSU (D) = (1− e−(
∑n
i=1 αdi+βd
2
i ))N0 ,
with
∑n
i=1 di = D. Given these assumptions, the random variable describing the proba-
bility that i FSUs are killed after applying a dose D is binomial distributed to the total
number of FSUs N in the organ and the probability PFSU (D). So we obtain
Pbin(i) =
(
N
i
)
(PFSU (D))
i(1− PFSU (D))N−i.
For a large number N of FSUs, the distribution approaches the normal distribution by
the central limit theorem, yielding
Pnorm(i) =
1
σ
√
2pi
e−
1
2(
i−µ
σ )
2
with µ = E(X) = NPFSU and σ
2 = Var(X) = NPFSU (1 − PFSU ). As we are looking for
the probability that the normal tissue cannot function properly after radiation, we have to
determine the probability that at least R FSUs or more (up to all FSUs N) are damaged.
Hence it is
NTCPcv(D) =
N∑
i=R
Pbin(i)
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and we obtain
NTCPcv(D) =
N∑
i=R
(
N
i
)
PFSU (D)
i(1− PFSU (D))N−i. (2.11)
Moreover, we can approximate
NTCPcv(D) =
N∑
i=R
Pbin(i) ≈
∫ ∞
R
Pnorm(i)di =
1
σ
√
2pi
∫ ∞
R
e−
1
2(
i−µ
σ )
2
di.
We can easily see that after rescaling with the parameter t = i−µσ , the critical volume
NTCP has the same form as in Lyman, compare equation (2.9).
NTCPcv(D) =
1√
2pi
∫ ∞
R−µ
σ
e
−t2
2 dt =
1√
2pi
∫ µ−R
σ
−∞
e
−t2
2 dt.
Special cases
Before we considered the general case that an organ is destroyed if R or more FSUs are
damaged. If an organ can only survive if all FSU are working properly then the organ
has a so-called critical element or serial architecture and we get the special case R = 1.
Equation (2.11) then reduces to the critical element NTCP
NTCPce(D) =
N∑
i=1
Pbin(i) = 1− Pbin(0) = 1− (1− PFSU )N .
Another special case is that the organ survives if at least one FSU survives (R = N).
Hence equation (2.11) reduces to
NTCPcv(D) = PFSU (D)
N .
Inhomogeneous Dose Distribution
So far we have assumed that the doses are homogeneously distributed on the tissue.
We now want to relax this assumption and consider an heterogenic dose distribution
on the irradiated tissue. Therefore we assume that the organ can be split into k near-
homogeneously irradiated sub-volumes [13], each one containing Ki FSUs and receiving
a dose Di. The total number of killed FSUs, N
inhom
FSU , is then the sum of all killed FSU
within the sub-volumes. This yields to
N inhomFSU =
k∑
i=1
KiP
i
FSU (Di)
with
∑R
i=1Ki = N. The effective probability to kill one FSU with a heterogeneous dose
distribution is given by
P effFSU =
N inhomFSU
N
.
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2.5 NTCP as a function of BED
Another concept for quality measure of radiation treatment is closely related to the im-
proved LQ-model (2.2) and was firstly introduced by [5]. Instead of looking at the whole
LQ-term we now only want to consider the exponent. We call the bracket term in (2.2)
the Biological Effective Dose (short: BED) and receive the following definition:
BEDα/β(n, d, T ) = nd
(
1 +
d
[α/β]
)
− ln 2 (T − Tk)
Tpα
with n ∈ N and d, Tk, Tp, T ∈ R+. It is a biologically effective dose for a tissue with a
particular α/β-ratio only. Fowler used the BED for treatment optimization in [5]. He
distinguished early and late side effects, whereby he assumed α/β = 10 for early responses
and α/β = 3 for late responses.
Assuming Poissonian statistics, the NTCP can be directly computed from the BED as
NTCPBED = exp(−n0 exp(−αBED))
L∑
k=0
(n0 exp(−αBED))k
k!
.
2.6 Summary of previous models
The NTCP models of Lyman and Niemierko are statistical models. Patient data on organ
damage and survival are used to estimate parameters such as TD50,m, σ. Later, in Section
3 we will derive a mechanistic NTCP model that is based on the biological properties of the
tissue at hand, allowing us to estimate the parameters based on organ tissue characteristics.
The biologically effective dose (BED) has been used for both, the tumor and the healthy
tissue, and corresponding optimization problems have been studied ([5]). The description
of the TCP by Zaider and Minerbo provides a new level of detail as compared to the BED,
for example. Any time-dependent treatment schedule can be included and the parameters
are given from a birth-death process of tumor growth. However, so far, there was no
cousin model for the NTCP which is based on an equally detailed description. The model
which we develop next, will enable us to compare TCP and NTCP on equal grounds; and
we will formulate a corresponding optimization problem in the discussion Section 5.
3 NTCP based on a stochastic logistic birth-death process
In this section we derive a NTCP model from a stochastic logistic birth-death process.
These are well known stochastic processes and detailed expositions can be found in the
textbooks of Allen [1] and Nisbet and Gurney [14]. The use of birth-death processes for
NTCP is inspired by the construction of a TCP from Zaider-Minerbo [16]. For our model
we make the following assumptions:
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1. Depending on the organ at hand, the entities of interest are either organ cells, or
organ functional subunits. To keep the notation transparent, we will talk about cells
in the following, but the model equally applies to functional subunits. We assume
that all healthy tissue cells (or functional subunits) in the irradiated domain are
identical and independent throughout the organ. We plan in future work to extend
this model and differentiate between stem cells and normal cells [8].
2. Furthermore we assume that an organ works properly if more than L cells (or func-
tional subunits) exist.
3. For a small time increment ∆t, the expression µ∆t denotes the probability of mitosis
in a time interval [t, t+∆t], where µ > 0 is the mitosis rate. We will assume that the
cell growth is limited by space and nutrition supply so the mitosis rate is dependent
on an organ-specific carrying capacity M . An increasing number of cells therefore
leads to a decreasing mitosis rate. Mathematically speaking we choose the mitosis
rate as follows:
µi =
{
µ(1− iM ), if i = 1, 2, ...,M
0, otherwise
(3.12)
The carrying capacity M refers to the organ size. If we count cell numbers then M
is usually a very large number (≈ 109) .
4. The term r(t) = ρ+h(t) denotes the removal rate, where ρ ≥ 0 denotes natural death
of cells and the hazard function h(t) death due to radiation (see (2.3) or (2.4)).
We denote Pi(t) as the probability that i ∈ N normal cells are alive at time t. The
probability that an organ cannot function properly anymore is then given by
Definition 3.1 (NTCP birth-death) The Normal Tissue Complication Probability based
on a birth-death process is defined as
NTCPbd(t) =
L∑
i=0
Pi(t). (3.13)
The master equation for the probabilities Pi(t) of the number of cells X is given by
dPi(t)
dt
= (i− 1)µi−1Pi−1(t) + (i+ 1)r(t)Pi+1(t)− i(µi + r(t))Pi(t), (3.14)
with initial values Pn0(0) = 1 and Pi(0) = 0 for i 6= n0, [4, 1]. For the TCP we were only
interested in the solution of P0(t). In contrast to that we are now interested in solving the
system for Pi(t) with i = 0, ..., L.
The mitosis rate as above guarantees that the number of normal tissue cells stays below
or equal to the carrying capacity M .
Lemma 3.1 ([4, 1]) Assume µi is given by (3.12). If Pi(0) = 0 for i ≥ M + 1, then
Pi(t) = 0 for i ≥M + 1, ∀t > 0, i.e. the system (3.14) is finite.
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Another interesting result shows that the mean field function E(X) (with X denoting the
random variable which describes the number of healthy tissue) obeys a logistic differential
equation with a perturbation that depends on the variance.
Lemma 3.2 ([1] Formula (6.28), p. 246)) Assume µi is given by (3.12). Provided the
series
N(t) = E(X) =
∞∑
i=0
iPi(t) (3.15)
converges, then N(t) is the mean field function of system (3.14) and satisfies a differential
equation
dN(t)
dt
= µN(t)
(
1− N(t)
M
)
− r(t)N(t)− µ
M
Var(X), (3.16)
where Var(X) is the variance of the normal tissue number and is defined as usual by
Var(X) = E((X −N(t))2).
Let us provide some remarks on Lemma 3.2:
1. It is interesting to note that the perturbation term µMVar(X) goes to zero for large
carrying capacity M , or for small variance. In those cases we obtain the standard
logistic differential equation for the expected number of cells N(t).
2. Since the variance is non negative, the mean field equation (3.16) is dominated by
the logistic equation
dZ
dt
= µZ(t)
(
1− Z(t)
M
)
− r(t)Z(t), (3.17)
i.e. N(t) ≤ Z(t) whenever they have the same initial condition N(0) = Z(0) (a fact
already known to Feller [4], see also [1]).
3. We rescale the mean field equation (3.16) into a relative occupancy y(t) := N(t)M .
Then y(t) satisfies
dy
dt
= µy(1− y)− r(t)y − µVarY, (3.18)
where the random variable Y is defined as Y = X/M .
These two previous results give us tools to compute the NTCP for the two complementary
cases of M is small and M is large. If M is small (say less than 1000), then we benefit
from Lemma 3.1, the system of equations (3.14) is of finite and manageable size, and we
can use a direct numerical computation to solve it. This is done in the next Section 3.1.
On the other hand, if M is large (larger than 1000, say), then we can use an asymptotic
method to approximate the NTCP as done in Section 3.2. We see that in this case the
NTCP is basically given by the logistic differential equation (3.17). If we compare these
two methods (for M = 500), we find that they coincide surprisingly well, suggesting that
the logistic differential equation (3.17) is appropriate in computing the NTCP. We outline
how it can be used in clinical practice in Section 4, where we also introduce the organ
specific maximal tolerable dose Dmax.
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Parameter Description Value
µA birth rate fast in [day
−1] 8.59
µB birth rate slow in [day
−1] 0.07
ρ natural death rate cells in[day−1] 0.03
M carrying capacity 500
L number of cells the organ needs to work properly 0.05 M
α sensitivity parameter in [Gy−1] 0.06
β sensitivity parameter in [Gy−2] 0.02
d dose rate in [Gy/day] 2.5, 3, 3.5
n0 initial number of cells M
Table 1: Parameter values for a generic α/β = 3 healthy tissue, taken from [6].
3.1 Numerical results for small M
After we have proved that the system of ODEs with µi is finite, we can now calculate the
result numerically. We define P (t) = (P0(t), P1(t), ..., PM (t))
T with Pi(t) from (3.14) and
obtain a corresponding forward Kolmogoroff equation [1]
dP
dt
= AP
with the transition matrix A
A =

0 r(t) 0 ... 0 0
0 −(µ1 + r(t)) 2r(t) ...
...
. . .
0 0 0 ... (M − 1)µM−1 −M(µM + r(t))
 .
For the initial values of the ODE system we chose a completely healthy organ at the
beginning of treatment, i.e. PM (0) = 1 and Pi(0) = 0 ∀i 6= M . Alternatively we can
also consider partially damaged organs such that Pn0(0) = 1 with n0 < M . We assume
continuous radiation per day with hazard function for uniform treatment (2.3) such that
r(t) =ρ+ (α+ 2βdt)d
µi =µ
(
1− i
M
)
, 0 < i ≤M.
For the simulation we used the valuesfrom Table 1 as taken from [6]. For the solution of
the ODE-system we used the built-in MATLAB solver ’ode45’. Fig. 2 shows the simulated
NTCP-curves for different constant dose rates (d= 2.5, 3.0, 3.5 Gy/day). On the left we
show the NTCP curves for tissue type A with µA = 8.59 and hazard function (2.3), where
on the right we have tissue type B with µB = 0.07 and hazard function (2.4). We observe
that an increasing dose rate leads to shorter times before the healthy tissue is dysfunctional.
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Figure 2: NTCP curves as function of time (days) for constant radiation dose d (Gy/day).
Left: tissue tpe A, µA = 8.59 and hazard function (2.3); Right: tissue type B with
µB = 0.07 and hazard function (2.4)
3.2 Asymptotics for large carrying capacity M
As mentioned before, in most cases, the carrying capacity M will be large. Hence it is
useful to consider the asymptotic limit of M → ∞. In this case we still have the finite
structure of the system of equations (3.14), but the system is large, and asymptotic meth-
ods are a good alternative. We will use a rescaling argument to identify the location where
the NTCP transfers from 0 to 1. It turns out that the mean field equation (3.17) plays an
important role for this transition.
The question we find ourselves confronted with now is if there is an asymptotic so that the
system of equations becomes independent of the size of the carrying capacity. Therefore
the computational limits would not affect the simulations any longer and we could make
capacity-independent predictions. To achieve this aim we will re-parameterize the system
of ODEs (3.14). As in the earlier numerical simulations we assume that the initial number
of cells is n0 = M . Therefore we get the initial values of the system PM (0) = 1 and
Pi(0) = 0 for i 6= M . For the parameterization we set
Pi(t) =
1
M
Φ
(
i
M
, t
)
=
1
M
Φ(x, t). (3.19)
where x ∈ [0, 1] is considered to be a continuous variable in the unit interval. The function
Φ is a probability density, since Φ ≥ 0 and∫ 1
0
Φ(x, t)dx ≈
M∑
i=0
1
M
Φ(
i
M
, t) =
M∑
i=0
Pi(t) = 1.
Hence we can modify our definition (3.13) of an NTCP as
NTCPΦ(t) =
∫ l
0
Φ(x, t)dx (3.20)
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with l = LM ∈ [0, 1]. The expectation becomes
N(t) = M
∫ 1
0
xΦ(x, t)dx.
We now introduce the rescaling into the master equation (3.14), where we have
i
M
= x, ∆x =
1
M
, ∆xM = 1, i+ 1 = (x+ ∆x)M, i− 1 = (x−∆x)M
and for the rescaled mitosis rate (3.12) we obtain
µ˜(x) =
{
µ(1− x), if x ∈ [0, 1]
0, otherwise.
(3.21)
Using this and (3.19) for (3.14) we obtain by Taylor-expansion with increment ∆x = 1M
(see also [14] eq. (6.2.18) on page 173) that
∂
∂t
Φ(x, t) =− ∂
∂x
[
(µx(1− x) + r(t)x)Φ(x, t)]
− ∆x
2
∂2
∂x2
[
(µx(1− x) + r(t)x)Φ(x, t)]
+O(∆x−2)
If ∆x is small enough, i.e. M large enough, then we can consider the leading order term
of the above expansion. We obtain a hyperbolic partial differential equation
∂
∂t
Φ(x, t) = − ∂
∂x
[
(µx(1− x)− r(t)x)Φ(x, t)
]
(3.22)
with initial values
Φ(1, 0) = Φ
(M
M
, 0
)
= MPM (0) = M.
Φ(x, 0) = Φ
( i
M
, 0
)
= MPi(0) = 0 for x ∈ [0, 1).
For M →∞ the above initial condition appears as a Dirac delta distribution
Φ(x, 0) = δ1(x).
We solve the PDE (3.22) analytically using the method of characteristics. Expanding the
spatial derivative we obtain
∂
∂t
Φ(x, t) +
[
µx(1− x)− r(t)x
] ∂
∂x
Φ(x, t) + (µ(1− 2x)− r(t))Φ(x, t) = 0.
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This hyperbolic PDE has the characteristic equations
dx
dt
= µx(1− x)− r(t)x x(0) = x0 (3.23)
dΦ
dt
= −(µ(1− 2x)− r(t))Φ, Φ(x, 0) = δ1(x). (3.24)
With the initial value of Φ being a Dirac delta distribution and (3.24) being linear in Φ,
we expect that Φ(x, t) = δx(t) is a weak solution of (3.22). Here x(t) is the solution of
(3.23) with the initial value x0 = 1. See [3] for a definition of a weak solution.
Definition 3.2 Φ ∈ D(Ω) = C∞∗0 (Ω) with Ω = [0, 1] is a weak solution of (3.22), if
d
dt
〈Φ, ζ〉 = −〈(µx(1− x)− r(t)x)Φ(x, t), ∂
∂x
ζ〉
for all ζ ∈ C∞0 (Ω).
In the following we will use the integral notation for the scalar product and write
∫
Φ(x, t)ζ(x)dx
instead of 〈Φ, ζ〉. We obtain the following theorem:
Theorem 3.3 Let x(t) be the solution of (3.23) with the initial value x(0) = 1. Then
Φ(x, t) = δx(t) is a weak solution of the PDE system (3.22).
Proof.
d
dt
∫
Φ(x, t)ϕ(x)dx =
∫
∂
∂t
Φ(x, t)ϕ(x)dx
= −
∫ (∫
∂
∂t
Φ(z, t)dz
)
∂
∂x
ϕ(x)dx
= −
∫ (∫
− ∂
∂z
((µz(1− z)− r(t)z)Φ(z, t))dz
)
∂
∂x
ϕ(x)dx
=
∫
(µx(1− x)− r(t)x)Φ(x, t) ∂
∂x
ϕ(x)dx
where we used partial integration and (3.22). Hence we obtain for Φ(x, t) = δx(t)
d
dt
∫
Φ(x, t)ϕ(x)dx =
∫
(µx(1− x)− r(t)x)Φ(x, t) ∂
∂x
ϕ(x)dx
⇔ d
dt
ϕ(x(t)) = (µx(t)(1− x(t))− r(t)x(t)) ∂
∂x
ϕ(x(t))
which is always true since
d
dt
ϕ(x(t)) =
dx(t)
dt
dϕ(x)
dx
= (µx(t)(1− x(t))− r(t)x(t)) ∂
∂x
ϕ(x(t))
with (3.23). Hence δx(t) is a weak solution of (3.22). 
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3.3 Comparison of the two methods for small and large M
We now want to compare this asymptotic result with the numerical solution from the
previous section, cp. Fig.2. Using the solution of Theorem 3.3 we find
NTCPΦ(t) =
∫ l
0
δx(t)(x)dx
with l = LM ∈ [0, 1]. This integral is either 0 if x(t) > l or 1 if x(t) < l. Hence the NTCPΦ
function is a heavyside function that jumps at t = x−1(l) from 0 to 1. The following
Figure 3 shows the solutions of the characteristic ODE (3.23), x(t), (dotted) for particular
irradiation doses, the threshold value l that indicates permanent damage on the healthy
tissue (magenta) and the resulting NTCPΦ- functions, which jump at the intersection point
of cell density function and tolerance value. The values we used for these simulations are
the same values we used for Fig. 2, with tissue A on the left and tissue B on the right.
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Figure 3: The dashed lines show the characteristics x(t) for the three treatment dosages
of 3.5, 3.0 and 2.5 Gy/day, for tissue A on the left and tissue B on the right. They start at
x(0) = 1 and decrease until they intersect the vertical line of x = L. At that intersection
the NTCP jumps from 0 to 1, indicated by a vertical line in the same color.
In Figure 4 we compare the approximate NTCP curves with the ones from the numerical
approach of Section 3.1 and we see the transition regions coincide extremely well. We tried
many more combinations of fast and slow regenerating tissues and various choices of hazard
functions (not shown) and the correspondence of the two NTCP methods was always very
good. Hence we succeeded in obtaining a carrying capacity independent formulation of
the NTCP.
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Figure 4: Overlay of the continuous NTCPs from Figure 2 and the jumps from the asymp-
totic analysis, Figure 3. Left tissue type A, right tissue type B.
4 Clinical significance and the maximal tolerable dose
Concerning the practical use of this NTCP, we propose an algorithm which is centered
around the logistic differential equation (3.17) which we rewrite for convenience:
dZ
dt
(t) = µZ(t)
(
1− Z(t)
M
)
− r(t)Z(t). (4.25)
We have seen in Lemma 3.2 that this equation approximates the mean field equations
(3.16) for large carrying capacity M or small variance. Moreover, if we consider the
relative abundance z(t) := Z(t)/M , then we obtain
dz
dt
(t) = µz(t)(1− z(t))− r(t)z(t),
which coincides with the characteristic equation (3.23) that was used in the asymptotic
method for large M . In Section 3.2 we found that the NTCPΦ jumps from 0 to 1 exactly
when the characteristic x(t) meets the threshold value l. Transforming back to the original
quantities Z(t), an equivalent condition is
Z(tmax) = L, (4.26)
where L is the minimal size for an organ to still function and tmax is the maximal treat-
ment time, for a given treatment, such that the healthy organ is not damaged permanently.
Specifically, we need the following clinical information:
Patient/organ specific:
1. radiosensitivity parameters of the healthy organ; α, β.
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Tissue A Tissue B
dose rate (Gy/day) tmax (day) Dmax (Gy) tmax (day) Dmax (Gy)
2.5 33 82.5 15.5 38.75
3 24 72 12 36
3.5 17 59.5 9.5 33.25
Table 2: Maximal treatment time tmax and maximal tolerable dosages Dmax for three
uniform radiation treatments. tissue A describes a fast repairing tissue, while tissue B is
slow repairing.
2. minimal viable size of the organ; L
3. initial organ size; Z(0)
4. normal organ size; M
5. mean organ repair rate if damaged; µ
Treatment specific:
1. treatment schedule, fractionated, hypo-hyper fractionation, brachyther-
apy etc.; D(t). The radiation sensitivity parameters α, β and the treat-
ment schedule D(t) enter the hazard function h(t) (2.3) or (2.4) and hence
the removal rate r(t).
We solve the logistic equation (4.25) until Z(tmax) = L to find the maximal tolerable
treatment time tmax. The corresponding maximal tolerable treatment dose is
Dmax = D(tmax).
As an example we use the parameter values of α/β = 3 from Table 1 for three uniform
treatments with dose rates d = 2.5, 3, 3.5 Gy/day and the two tissue types A and B.
The NTCP curves were shown in Figure 4 (right). The maximal tolerable dose and the
maximal time of exposure in these cases are listed in Table 2.
5 Conclusions
We introduced a mathematical model for the normal tissue complication probability
(NTCP), which is based on patient specific, organ specific and treatment specific pa-
rameters. This of course means that we do not provide a one-fits-all formula. Rather, we
present a framework such that in a given situation, a NTCP can be derived. The analy-
sis of the stochastic birth-death process suggests to use the logistic differential equation
(3.17) as a good indicator of the NTCP. Hence the model is no longer complicated, rather,
it is mathematically simple. There is even an explicit solution to the logistic equation.
Moreover, the number of parameters that are needed is quite limited (α, β, Z(0),M,L)
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and there is real hope that these parameters can be estimated for many healthy tissues
in the future. If this is achieved, we obtain a biologically-based formulation of the NTCP
instead of a statistically based NTCP as the one by Lyman, for example.
The choice of hazard function h(t) is very important and to illustrate our method we
considered two different extreme cases of tissues. For tissue A we assumed that it repairs
tissue very quickly, however, single strand breaks can interact disrespective the time they
were created, (2.3). Tissue B repairs very slowly and single strand breaks can only interact
if they are no more than 6h apart (2.4). Our method worked very well for these extreme
cases, as well as for other combinations which we did not show here.
In a next step we can then compare the tumor control probability to the NTCP and
formulate a constraint optimization problem and an optimal control problem. These are
based on the following patient specific and organ specific parameters:
• radio sentisitvities of tumor at hand; αt, βt and initial tumor size n0.
• radio sensitivities of the involved healthy tissue; αh, βh
• initial size of the healthy tissue Z0, the normal size of the healthy tissue M , and the
minimal tolerable size of the organ at hand L.
• tumor growth rate b, and tumor death rate rt(t) based on a radiation schedule D(t)
• healthy tissue repair rate µ, and death rate of healthy tissue due to treatment rh(t),
given by a treatment D(t), which can include a dose-volume histogram of the exposed
healthy tissue.
In the following we denote by D the set of admissible treatment schedules consisting of
certain functions D : [0, tmax]→ R+. Note that D can include restrictions on the maximal
dose in total and per time interval and further a-priori choices on the type of treatment
(e.g. discrete radiation events, continuous radiation, weekends off, etc.). For a given
treatment schedule D let (n(·;D), Z(·;D)) denote the solutions of
dn
dt
= (b− rt(t))n, n(0) = n0
dZ
dt
= µZ
(
1− Z
M
)
− rh(t)Z, Z(0) = Z0.
Note that the variable D(t) enters the radiation induced death rates rt(t), rh(t) through
the hazard functions.
The goal of the radiation therapy taking into account TCP and NTCP is to achieve tumor
control in a certain time interval while restricting the damage. Note that the first means
to have TCP equal to one at final time tmax, which can be expressed already by the formula
of Zaider-Minerbo (2.8). The constraint has to be formulated in the whole time interval
[0, tmax] however, since too strong damage during the treatment cannot guarantee recovery
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even if the NTCP is again below a threshold at time tmax.
Control problem: Find D ∈ D such that
TCPZM (tmax) =
(
1− n(tmax;D)
n0 + bn0
∫ tmax
0
dt
n(t;D)
)n0
= 1, Z(t;D) ≥ L for all 0 < t ≤ tmax.
Since it may be difficult or even impossible to achieve exact controllability in a finite time
interval, we alternatively formulate an optimization problem rather in the tradition of
optimizing treatment schedules:
Optimization problem:
max
D∈D
TCPZM (tmax), Z(t;D) ≥ L for all 0 < t ≤ tmax.
The analysis of this optimization problem and the control problem depends on specific
choices of D and parameters, which exceeds the scope of this paper and it is an interesting
problem for future research.
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